Cargando…
PB1971: A PHASE 1 MULTICENTER OPEN-LABEL DOSE-ESCALATION AND DOSE-EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, EFFICACY OF HS-10382 (TERN-70) IN CHRONIC MYELOID LEUKEMIA PATIENTS
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430229/ http://dx.doi.org/10.1097/01.HS9.0000974700.92818.27 |
| _version_ | 1785090911457247232 |
|---|---|
| author | LI, Weiming Xu, Na Xu, Zhongyuan Zhang, Yanli LI, Junmin Zhu, Huanling Zheng, LI Yan, Xiaojing Du, Xin Hu, Yu |
| author_facet | LI, Weiming Xu, Na Xu, Zhongyuan Zhang, Yanli LI, Junmin Zhu, Huanling Zheng, LI Yan, Xiaojing Du, Xin Hu, Yu |
| author_sort | LI, Weiming |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430229 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104302292023-08-17 PB1971: A PHASE 1 MULTICENTER OPEN-LABEL DOSE-ESCALATION AND DOSE-EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, EFFICACY OF HS-10382 (TERN-70) IN CHRONIC MYELOID LEUKEMIA PATIENTS LI, Weiming Xu, Na Xu, Zhongyuan Zhang, Yanli LI, Junmin Zhu, Huanling Zheng, LI Yan, Xiaojing Du, Xin Hu, Yu Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430229/ http://dx.doi.org/10.1097/01.HS9.0000974700.92818.27 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only LI, Weiming Xu, Na Xu, Zhongyuan Zhang, Yanli LI, Junmin Zhu, Huanling Zheng, LI Yan, Xiaojing Du, Xin Hu, Yu PB1971: A PHASE 1 MULTICENTER OPEN-LABEL DOSE-ESCALATION AND DOSE-EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, EFFICACY OF HS-10382 (TERN-70) IN CHRONIC MYELOID LEUKEMIA PATIENTS |
| title | PB1971: A PHASE 1 MULTICENTER OPEN-LABEL DOSE-ESCALATION AND DOSE-EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, EFFICACY OF HS-10382 (TERN-70) IN CHRONIC MYELOID LEUKEMIA PATIENTS |
| title_full | PB1971: A PHASE 1 MULTICENTER OPEN-LABEL DOSE-ESCALATION AND DOSE-EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, EFFICACY OF HS-10382 (TERN-70) IN CHRONIC MYELOID LEUKEMIA PATIENTS |
| title_fullStr | PB1971: A PHASE 1 MULTICENTER OPEN-LABEL DOSE-ESCALATION AND DOSE-EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, EFFICACY OF HS-10382 (TERN-70) IN CHRONIC MYELOID LEUKEMIA PATIENTS |
| title_full_unstemmed | PB1971: A PHASE 1 MULTICENTER OPEN-LABEL DOSE-ESCALATION AND DOSE-EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, EFFICACY OF HS-10382 (TERN-70) IN CHRONIC MYELOID LEUKEMIA PATIENTS |
| title_short | PB1971: A PHASE 1 MULTICENTER OPEN-LABEL DOSE-ESCALATION AND DOSE-EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, EFFICACY OF HS-10382 (TERN-70) IN CHRONIC MYELOID LEUKEMIA PATIENTS |
| title_sort | pb1971: a phase 1 multicenter open-label dose-escalation and dose-expansion study to evaluate the safety, tolerability, pharmacokinetics, efficacy of hs-10382 (tern-70) in chronic myeloid leukemia patients |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430229/ http://dx.doi.org/10.1097/01.HS9.0000974700.92818.27 |
| work_keys_str_mv | AT liweiming pb1971aphase1multicenteropenlabeldoseescalationanddoseexpansionstudytoevaluatethesafetytolerabilitypharmacokineticsefficacyofhs10382tern70inchronicmyeloidleukemiapatients AT xuna pb1971aphase1multicenteropenlabeldoseescalationanddoseexpansionstudytoevaluatethesafetytolerabilitypharmacokineticsefficacyofhs10382tern70inchronicmyeloidleukemiapatients AT xuzhongyuan pb1971aphase1multicenteropenlabeldoseescalationanddoseexpansionstudytoevaluatethesafetytolerabilitypharmacokineticsefficacyofhs10382tern70inchronicmyeloidleukemiapatients AT zhangyanli pb1971aphase1multicenteropenlabeldoseescalationanddoseexpansionstudytoevaluatethesafetytolerabilitypharmacokineticsefficacyofhs10382tern70inchronicmyeloidleukemiapatients AT lijunmin pb1971aphase1multicenteropenlabeldoseescalationanddoseexpansionstudytoevaluatethesafetytolerabilitypharmacokineticsefficacyofhs10382tern70inchronicmyeloidleukemiapatients AT zhuhuanling pb1971aphase1multicenteropenlabeldoseescalationanddoseexpansionstudytoevaluatethesafetytolerabilitypharmacokineticsefficacyofhs10382tern70inchronicmyeloidleukemiapatients AT zhengli pb1971aphase1multicenteropenlabeldoseescalationanddoseexpansionstudytoevaluatethesafetytolerabilitypharmacokineticsefficacyofhs10382tern70inchronicmyeloidleukemiapatients AT yanxiaojing pb1971aphase1multicenteropenlabeldoseescalationanddoseexpansionstudytoevaluatethesafetytolerabilitypharmacokineticsefficacyofhs10382tern70inchronicmyeloidleukemiapatients AT duxin pb1971aphase1multicenteropenlabeldoseescalationanddoseexpansionstudytoevaluatethesafetytolerabilitypharmacokineticsefficacyofhs10382tern70inchronicmyeloidleukemiapatients AT huyu pb1971aphase1multicenteropenlabeldoseescalationanddoseexpansionstudytoevaluatethesafetytolerabilitypharmacokineticsefficacyofhs10382tern70inchronicmyeloidleukemiapatients |